Dihydroergotamine Mesylate Injection 1 mg/mL Recall
Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05
What is the FDA recall status?
The FDA record lists this recall as ongoing. FDA enforcement data is not a live recall-lifecycle tracker. Follow the official instructions and check the agency notice or firm for current guidance.
Why was Dihydroergotamine Mesylate Injection 1 mg/mL recalled?
Discoloration
What should I do if I have this product?
Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.
Full product description
Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05
Which lot codes, UPCs or models are affected?
Lot #: F9026F01, F9026F02, Exp. Date 12/2025
- Agency record number
- D-0150-2025
- Product
- Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05
- Recalling firm
- Provepharm Inc.
- Quantity
- 2160 packs/5 ampules per pack = 10,800 ampules
- Distribution
- Nationwide within the United States
- Recall started
- November 22, 2024
- Report date
- December 25, 2024
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)